SK

Sunil Kumar Gupta

Active Director Cfo DIN 02202264
DIN 02202264 First appointment May 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since May 2008
Shareholding value •••• Premium profile

About Sunil Kumar Gupta

Data last updated:

Sunil Kumar Gupta is a Cfo at Orchid Pharma Limited (since 2020) and Cfo at Orchid Bio-Pharma Limited (since 2023). The companies operate in Pharma and Business Outsourcing. The 2 current companies with reported revenue have a combined latest revenue of ₹950 Cr; the largest is Orchid Pharma Limited at ₹949 Cr (FY 2025). Earlier, Sunil Kumar Gupta was a Cfo at Dhanuka Laboratories Limited (2016–2023) and Director at Minda Capital Private Limited (2008).

DIN 02202264
Primary Designation Cfo
Industry Pharma
First Appointment 19 May 2008
Oldest Company Age 34 yrs
Largest company Orchid Pharma Limited · ₹949 Cr (FY 2025)
Combined revenue ₹950 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Orchid Pharma Limited L24222TN1992PLC022994
Cfo29 Jun 20201992₹949 Cr (FY 2025)Active
Orchid Bio-Pharma Limited U24230TN2022PLC150784
Cfo17 May 20232022₹43.3 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dhanuka Laboratories Limited U24100TN1993PLC149053
Cfo05 Apr 20161993₹1,424 Cr (FY 2025)Active
Minda Capital Private Limited U31300DL1996PTC083438
Director19 May 20081996₹77.37 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Orchid Pharma Limited
Orchid Bio-Pharma Limited
Dhanuka Laboratories Limited
Minda Capital Private Limited
Premium access

Shareholding and investment profile for Sunil Kumar Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Kumar Gupta

Sunil Kumar Gupta currently holds 2 directorships: Orchid Pharma Limited (Cfo, since 29 Jun 2020, revenue ₹949 Cr (FY 2025)); Orchid Bio-Pharma Limited (Cfo, since 17 May 2023, revenue ₹43.3 Lakh (FY 2025)).

Sunil Kumar Gupta was first appointed on 19 May 2008 as Director at Minda Capital Private Limited. The most recent appointment on record is 17 May 2023 at Orchid Bio-Pharma Limited.

The 2 current companies of Sunil Kumar Gupta that report revenue have a combined latest revenue of ₹950 Cr: Orchid Pharma Limited ₹949 Cr (FY 2025); Orchid Bio-Pharma Limited ₹43.3 Lakh (FY 2025).

Sunil Kumar Gupta held 2 earlier board appointments: Dhanuka Laboratories Limited (Cfo, 05 Apr 2016 to 16 May 2023); Minda Capital Private Limited (Director, 19 May 2008 to 14 Oct 2008).

The current boards of Sunil Kumar Gupta's companies include Arjun Dhanuka (Orchid Pharma Limited), Dharam Vir (Orchid Pharma Limited), Kapil Dayya (Orchid Pharma Limited), Manish Dhanuka (Orchid Pharma Limited), Manoj Kumar Goyal (Orchid Pharma Limited), Mridul Dhanuka (Orchid Pharma Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available